Stratos Wealth Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $721K | Sell |
11,485
-9,696
| -46% | -$776K | 0.01% | 924 |
|
|
2025
Q4 | $2.02M | Sell |
21,181
-1,091
| -5% | -$107K | 0.02% | 548 |
|
|
2025
Q3 | $2.17M | Buy |
22,272
+2,582
| +13% | +$267K | 0.03% | 512 |
|
|
2025
Q2 | $2.11M | Buy |
19,690
+13,011
| +195% | +$1.32M | 0.03% | 476 |
|
|
2025
Q1 | $674K | Sell |
6,679
-16,911
| -72% | -$1.7M | 0.01% | 789 |
|
|
2024
Q4 | $2.11M | Buy |
23,590
+13,597
| +136% | +$1.2M | 0.03% | 461 |
|
|
2024
Q3 | $837K | Sell |
9,993
-23,053
| -70% | -$1.82M | 0.01% | 752 |
|
|
2024
Q2 | $2.54M | Buy |
33,046
+3,470
| +12% | +$254K | 0.04% | 389 |
|
|
2024
Q1 | $2.03M | Buy |
29,576
+18,348
| +163% | +$1.18M | 0.03% | 435 |
|
|
2023
Q4 | $649K | Buy |
11,228
+2,611
| +30% | +$139K | 0.01% | 773 |
|
|
2023
Q3 | $455K | Buy |
8,617
+182
| +2% | +$9.54K | 0.01% | 852 |
|
|
2023
Q2 | $456K | Sell |
8,435
-2,376
| -22% | -$124K | 0.01% | 800 |
|
|
2023
Q1 | $541K | Buy |
10,811
+964
| +10% | +$45.4K | 0.01% | 672 |
|
|
2022
Q4 | $456K | Buy |
9,847
+675
| +7% | +$29.2K | 0.01% | 761 |
|
|
2022
Q3 | $355K | Sell |
9,172
-425
| -4% | -$17K | 0.01% | 801 |
|
|
2022
Q2 | $358K | Buy |
9,597
+817
| +9% | +$33.3K | 0.01% | 856 |
|
|
2022
Q1 | $389K | Sell |
8,780
-82
| -0.9% | -$3.55K | 0.01% | 903 |
|
|
2021
Q4 | $376K | Buy |
8,862
+200
| +2% | +$8.4K | 0.01% | 921 |
|
|
2021
Q3 | $376K | Buy |
8,662
+249
| +3% | +$11K | 0.01% | 867 |
|
|
2021
Q2 | $360K | Buy |
8,413
+401
| +5% | +$16.9K | 0.01% | 900 |
|
|
2021
Q1 | $310K | Buy |
8,012
+1,739
| +28% | +$65.8K | 0.01% | 871 |
|
|
2020
Q4 | $226K | Sell |
6,273
-470
| -7% | -$16.9K | 0.01% | 959 |
|
|
2020
Q3 | $258K | Buy |
6,743
+274
| +4% | +$10.6K | 0.01% | 839 |
|
|
2020
Q2 | $227K | Sell |
6,469
-506
| -7% | -$18.2K | 0.01% | 858 |
|
|
2020
Q1 | $228K | Buy |
6,975
+351
| +5% | +$13.7K | 0.01% | 769 |
|
|
2019
Q4 | $300K | Buy |
6,624
+1,076
| +19% | +$45K | 0.01% | 756 |
|
|
2019
Q3 | $226K | Buy |
5,548
+617
| +13% | +$26.1K | 0.01% | 837 |
|
|
2019
Q2 | $212K | Buy |
+4,931
| New | +$190K | 0.01% | 858 |
|
|
2018
Q4 | – | Sell |
-3,088
| Closed | -$119K | – | 1016 |
|
|
2018
Q3 | $119K | Buy |
+3,088
| New | +$108K | 0.01% | 1045 |
|
|
2018
Q2 | – | Sell |
-1,790
| Closed | -$49K | – | 1165 |
|
|
2018
Q1 | $49K | Sell |
1,790
-1,291
| -42% | -$35.1K | ﹤0.01% | 1583 |
|
|
2017
Q4 | $76K | Buy |
+3,081
| New | +$85K | ﹤0.01% | 1311 |
|
Other funds holding BSX
VCM
VPM
Stratos Wealth Partners's BSX Position: Q1 2026 in Review
Stratos Wealth Partners reduced its Boston Scientific (BSX) stake by 46% in Q1 2026, selling an estimated $776K and leaving 11,485 shares worth $721K. The position accounts for 0.01% of the portfolio, ranked #924.
Stratos Wealth Partners first reported a position in BSX in Q4 2017 and has held it in 31 quarters since. The position peaked at $2.54M in Q2 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Stratos Wealth Partners held 11,485 shares of Boston Scientific worth $721K as of Q1 2026.
- Stratos Wealth Partners sold 9,696 Boston Scientific shares in Q1 2026, an estimated $776K.
- Boston Scientific made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #924 holding.
- Stratos Wealth Partners first reported a position in Boston Scientific in Q4 2017 and has held it in 31 quarters since.
- Stratos Wealth Partners's Boston Scientific position peaked at $2.54M in Q2 2024.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.